Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL349303

CC(C)CCCCCO.O=C(O)C(F)(F)F

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4C Q9H3R0 2/20 0.39
KDM4A O75164 1/20 0.39
PHF8 Q9UPP1 1/20 0.39
KDM2A Q9Y2K7 1/20 0.39
BLM P54132 1/20 0.38
ATR Q13535 1/20 0.37
GPR84 Q9NQS5 3/20 0.37
FFAR1 O14842 1/20 0.37
FFAR4 Q5NUL3 1/20 0.37
ACACB O00763 1/20 0.36
ACACA Q13085 1/20 0.36
LMNA P02545 1/20 0.34
MAPT P10636 1/20 0.34
ACE2 Q9BYF1 1/20 0.32
RARB P10826 1/20 0.32
FAAH O00519 2/20 0.31
KDM4E B2RXH2 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
CES2 O00748 1/20 0.31
CES1 P23141 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Isostearyl Alcohol SCHEMBL27628476 0.86 ACACB (0.41) KDM4CKDM4APHF8KDM2ABLM
Bicarbonate SCHEMBL10889200 0.85 BLM (0.45) KDM4CKDM4APHF8KDM2ABLM
Acetic Acid SCHEMBL27984992 0.83 BLM (0.43) KDM4CKDM4APHF8KDM2ABLM
Acetic Acid SCHEMBL1427501 0.83 BLM (0.43) KDM4CKDM4APHF8KDM2ABLM
Trifluoroacetic Acid SCHEMBL31384180 0.82 GPR84 (0.50) ATRGPR84FFAR1FFAR4LMNA
Trifluoroacetic Acid SCHEMBL31384178 0.82 GPR84 (0.50) ATRGPR84FFAR1FFAR4LMNA
SCHEMBL28582030 0.81 BLM (0.47) KDM4CKDM4APHF8KDM2ABLM
SCHEMBL26877 0.80
SCHEMBL20345 0.80 LMNA (0.50) KDM4CKDM4APHF8KDM2ABLM
SCHEMBL3778363 0.80 LMNA (0.50) KDM4CKDM4APHF8KDM2ABLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8647882-B2 Chiral selectors and stationary phases for separating enantiomer mixtures EVONIK DEGUSSA GMBH (DE) 2014-02-11 US disclosed
US-8268631-B2 Chiral selectors and stationary phases for separating enantiomer mixtures EVONIK DEGUSSA GMBH (DE) 2012-09-18 US disclosed
US-20120015443-A1 NOVEL CHIRAL SELECTORS AND STATIONARY PHASES FOR SEPARATING ENANTIOMER MIXTURES EVONIK DEGUSSA GMBH (DE) 2012-01-19 US disclosed
US-20090229352-A1 NOVEL CHIRAL SELECTORS AND STATIONARY PHASES FOR SEPARATING ENANTIOMER MIXTURES EVONIK DEGUSSA GMBH (DE) 2009-09-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120015443-A1 NOVEL CHIRAL SELECTORS AND STATIONARY PHASES FOR SEPARATING ENANTIOMER MIXTURES BCAT2, BCAT1, SLC43A1 KDM4C 4210/4885KDM4A 3226/4885PHF8 4031/4885
US-20090229352-A1 NOVEL CHIRAL SELECTORS AND STATIONARY PHASES FOR SEPARATING ENANTIOMER MIXTURES BCAT2, BCAT1, SLC43A1 KDM4C 4210/4885KDM4A 3226/4885PHF8 4031/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.